🇺🇸 High Dose PF-07328948 in United States

High Dose PF-07328948 (high-dose-pf-07328948) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Pricing & reimbursement

High Dose PF-07328948 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in United States

Frequently asked questions

Is High Dose PF-07328948 approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for High Dose PF-07328948 in United States?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.

What does High Dose PF-07328948 cost in United States?

annual_list: USD 15300.00 per year. Final patient cost depends on reimbursement and any patient access scheme.